See the DrugPatentWatch profile for Methylprednisolone
Methylprednisolone sodium succinate is a corticosteroid medication used to treat a variety of conditions. Hikma Pharmaceuticals manufactures a generic version of this drug.
What is Methylprednisolone Sodium Succinate Used For?
Methylprednisolone sodium succinate is prescribed for conditions such as severe allergies, asthma, arthritis, inflammatory bowel diseases, skin conditions, and certain types of cancer. It works by reducing inflammation and suppressing the immune system [1].
How Does Methylprednisolone Sodium Succinate Work?
As a corticosteroid, methylprednisolone sodium succinate mimics the effects of hormones produced by the adrenal glands. It binds to glucocorticoid receptors within cells, which leads to a cascade of events that reduce the production of inflammatory substances and modulate immune responses [1].
When Does Hikma's Methylprednisolone Sodium Succinate Patent Expire?
Information regarding specific patent expiration dates for generic medications like Hikma's methylprednisolone sodium succinate is often complex and subject to various factors, including market exclusivity and patent challenges. For detailed patent information, resources such as DrugPatentWatch.com can provide comprehensive data on patent statuses and expiry dates [2].
What Are the Potential Side Effects?
Common side effects of methylprednisolone sodium succinate can include increased appetite, mood changes, difficulty sleeping, and increased risk of infection. More serious side effects may involve changes in blood sugar levels, fluid retention, bone thinning (osteoporosis), and gastrointestinal issues [1].
How Does Methylprednisolone Sodium Succinate Compare to Other Steroids?
Methylprednisolone sodium succinate is a synthetic corticosteroid. Its potency and duration of action differ from other corticosteroids like prednisone or dexamethasone, influencing its specific clinical applications and dosing [1].
Who Else Manufactures Methylprednisolone Sodium Succinate?
Besides Hikma Pharmaceuticals, other pharmaceutical companies also manufacture generic methylprednisolone sodium succinate. The availability of generic versions typically increases competition and can affect pricing.
What Are the Regulatory Approvals for Methylprednisolone Sodium Succinate?
Methylprednisolone sodium succinate, including generic formulations, is approved by regulatory agencies like the U.S. Food and Drug Administration (FDA) for its indicated uses. These approvals are based on demonstrated safety and efficacy.
What Clinical Data Supports its Use?
Extensive clinical trials have been conducted on methylprednisolone and its sodium succinate ester to establish its efficacy and safety profile across various inflammatory and autoimmune conditions. This data forms the basis for its prescribing information [1].
Sources:
[1] National Institutes of Health. (n.d.). Methylprednisolone. MedlinePlus. Retrieved from https://medlineplus.gov/druginfo/meds/a682011.html
[2] DrugPatentWatch.com. (n.d.). Methylprednisolone Sodium Succinate. Retrieved from https://www.drugpatentwatch.com/